Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Karen Rosnes Gissum defended June 28, 2024 her PhD thesis "Unveiling the Complexities: Patients’ and Healthcare Providers’ Perspectives on Understanding and Managing Ovarian Cancer" at the University of Bergen. This is a unique CCBIO doctorate work focusing on the patient and healthcare worker perspective and not the actual research. Nevertheless, objective measures like biomarkers were seen as... Read more
In a new doctoral work at CCBIO, by Christiane Helgestad Gjerde, the group has established a 3D in vitro model of high-grade serous ovarian carcinoma to assess the efficacy of traditional chemotherapy and novel cell-based immunotherapies. This model makes out a more realistic mini tumor, making it possible to test which therapy that works on this type of cancer. The knowledge provided from this... Read more
European Society for Medical Oncology (ESMO) has held its annual Gynaecological Cancers Congress this year in Florence, Italy, 20-22nd June, 2024.
The doctoral work of Ole Vidhammer Bjørnstad, which includes three coming scientific papers, has shed light on the occurrence of neural precursor cells in breast cancer, and the interactions between neural precursor cells and breast cancer cells.
Karen Rosnes Gissum June 28, 2024 defends her doctoral work at the University of Bergen with the thesis "Unveiling the Complexities: Patients’ and Healthcare Providers’ Perspectives on Understanding and Managing Ovarian Cancer". The trial lecture is the same day.
The Norwegian Academy of Science and Letters June 12th announced the 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience. Among these are Robert S. Langer (USA), sharing the 2024 Kavli Prize in Nanoscience with Armand Paul Alivisatos (USA) and Chad A. Mirkin (USA).
Although patient involvement in research was not part of the program at the 12th CCBIO Annual Symposium, it is a topic CCBIO will give more attention to. We had a chat with a user representative who participated at the symposium, and who is also contributing in one of our research projects.
The 12th CCBIO Annual Symposium has recently taken place, with a program showcasing current cancer biomarker research. This was the final symposium in CCBIO’s 10-year period funded by the Research Council of Norway as a Centre of Excellence (CoE), however not the last. CCBIO will continue its core activities, maintaining what has become a strong cancer research network.
Although CCBIO this summer completes its 10-year appointment as Center of Excellence by the Research Council of Norway, the center will continue its activities, and so do all the research groups and collaborations that have been established through these years. It has been a privilege for the CCBIO leadership to follow these groups from the very beginning and watch them grow and now continue to... Read more
The 12th CCBIO Annual Symposium took place May 14-15, 2024, at Solstrand outside of Bergen in excellent weather, facilitating a radiant frame for networking and meetings in the sunshine during the breaks. The program showcased current cancer biomarker research as well as taking a step back considering global perspectives on cancer.
The Norwegian Society of Pathology celebrated the first 100 years with a symposium on Updates and Future of Pathology. The event was supported by CCBIO and also celebrated with a history book covering the Society and its activities through 1923-2023.
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
Emmet McCormack will be part of the new COST Action IMMUNO-model, where a network of scientists involved in the development and implementation of preclinical models evaluating the response and toxicity induced by immunotherapies, is challenged to expand our knowledge in their mechanisms of action and improve the survival and quality of life of cancer patients.
Forsker Grand Prix took place in Bergen September 27, where nine young researchers were competing for Best Presenter, getting only four minutes to convey their research in front of an audience and three judges. Among the nine was CCBIO's and the Department of Clinical Science's PhD Candidate Christiane Helgestad Gjerde.
The 11th CCBIO Annual Symposium was this time enlarged with a generous time frame and two overnight stays, May 8-11, 2023. Although there was an option for online attendance, only 14 participants chose to attend online, and the rest of the total of 235 chose to enjoy the company of colleagues and the informal and mutually fertilizing scientific crosstalk in the breaks and the evenings.
This winter/spring, three of CCBIO's students got the opportunity to have research stays at different labs of the Vascular Biology Program in Boston, through CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Camilla Tvedt Ekanger, Medical Student Research Program student Amalie Bark Kvamme and PhD Candidate Ole Vidhammer Bjørnstad are now back... Read more

Pages